Isgir Betul Bahar, Kocaman Gokhan, Kahya Yusuf, Ozakinci Hilal, Elhan Atilla Halil, Yuksel Cabir
Department of Thoracic Surgery, Ankara University, 06230, Ankara, Turkey.
Department of Pathology, Ankara University, 06230, Ankara, Turkey.
Updates Surg. 2025 Jan;77(1):201-208. doi: 10.1007/s13304-024-02000-4. Epub 2024 Nov 3.
Adenocarcinomas, a common subtype of lung cancer, exhibit diverse histological patterns. In 2020, The International Association for the Study of Lung Cancer (IASLC) introduced a grading system emphasizing high-grade components, which has shown prognostic value. Spread through air spaces (STAS) is recognized as a prognostic feature increasing the risk of recurrence in lung cancer. This study evaluates the combination of STAS status and the IASLC-grading system in surgically resected Stage I lung adenocarcinomas. This study is a retrospective analysis of 123 patients with Stage I lung adenocarcinoma who underwent lobectomy between 2011 and 2019. Histological patterns were assessed according to the IASLC criteria, and STAS status was documented. Patients were categorized based on their IASLC Grade and STAS status. Statistical analyses included Kaplan-Meier survival estimates, Cox proportional hazards models, and comparisons using Chi-square and t-tests. The cohort comprised 43 females and 80 males with a mean age of 61.8 ± 7.6 years. STAS positivity was noted in 52.8% of patients. STAS positivity correlated significantly with Grade 3 tumors (p < 0.001). The 5-year recurrence-free survival was significantly lower in STAS-positive patients (70.7% vs. 88.7%, p = 0.026). Patients with Grade 3 and STAS positivity had significantly lower recurrence-free survival compared to other groups (p = 0.002). Grade 3 and STAS positivity were independent predictors of poor recurrence-free survival in multivariate analysis. IASLC Grade 3 tumors and STAS positivity are independent prognostic factors for poor recurrence-free survival in Stage I lung adenocarcinomas. Adjuvant treatment strategies should be considered for patients with these characteristics to improve outcomes.
腺癌是肺癌的一种常见亚型,具有多种组织学模式。2020年,国际肺癌研究协会(IASLC)引入了一种强调高级别成分的分级系统,该系统已显示出预后价值。气腔播散(STAS)被认为是一种预后特征,会增加肺癌复发风险。本研究评估了STAS状态与IASLC分级系统在手术切除的I期肺腺癌中的联合应用。本研究是一项对2011年至2019年间接受肺叶切除术的123例I期肺腺癌患者的回顾性分析。根据IASLC标准评估组织学模式,并记录STAS状态。根据患者的IASLC分级和STAS状态进行分类。统计分析包括Kaplan-Meier生存估计、Cox比例风险模型以及使用卡方检验和t检验进行比较。该队列包括43名女性和80名男性,平均年龄为61.8±7.6岁。52.8%的患者STAS呈阳性。STAS阳性与3级肿瘤显著相关(p<0.001)。STAS阳性患者的5年无复发生存率显著较低(70.7%对88.7%,p=0.026)。与其他组相比,3级且STAS阳性的患者无复发生存率显著较低(p=0.002)。在多变量分析中,3级和STAS阳性是无复发生存不良的独立预测因素。IASLC 3级肿瘤和STAS阳性是I期肺腺癌无复发生存不良的独立预后因素。对于具有这些特征的患者,应考虑辅助治疗策略以改善预后。